Yuri Deigin - Partial Reprogramming Drug Development for Aging

<p>Yuri Deigin, co-founder of YouthBio Therapeutics, discusses developing rejuvenation gene therapies based on partial reprogramming and his role reinvigorating investigations into the origins of SARS-CoV-2.</p> <p>The Bioinformatics CRO is a fully distributed contract research company that serves the computational biology needs of biotechnology companies, with a focus on genomics.</p> <p>https://www.bioinformaticscro.com/</p>